Latest from ESMO congresses
The ESMO Daily Reporter is the official ESMO newspaper providing live reporting, highlights, critical insights on data presented at ESMO congresses, and expert opinions on controversial topics.
Newsroom
Read the latest news and updates from ESMO and the oncology community
Resources for Media
For media interested in reporting on cancer issues, check for the latest press releases and press briefings, abstract announcements, embargo policies, meeting information and tailored resources.
The unique needs of LGBTQ cancer patients are still poorly understood
An in-depth reflection on gaps in medical knowledge and research with Emmanouil Saloustros and Liz Margolies
Society Updates
ESMO Welcomes the WHO’s Historic Global Accord on Pandemic Prevention, Preparedness and Response
ESMO delivered an official statement at the Special Session of the World Health Assembly to strengthen pandemic prevention, preparedness and response
CORONAVIRUS: Update from ESMO
The ESMO Immuno-Oncology Congress will be an online-only meeting
Covid and Cancer Portal
Latest news and resources to tackle the pandemic era
Oncology News
A Phase III Study of Spartalizumab in Combination with Dabrafenib and Trametinib Did Not Meet Primary Endpoint in BRAF V600–Mutated Metastatic Melanoma
Findings from the COMBI-I study
Tucatinib Added to Trastuzumab and Capecitabine Continues to Demonstrate a Significant OS Improvement in Patients with HER2-positive Metastatic Breast Cancer
Final overall survival analysis from the HER2CLIMB study
Adjuvant Capecitabine-Containing Regimen Improves Modestly Overall Survival in Patients with Early Breast Cancer
Findings from the FinXX study